Psychedelic Stocks Pharmadrug Inc. (CSE:BUZZ) Ready To Leverage Opportunities In Germany Following Approval Of Psilocybin Study By Larry Zweig November 30, 2020 Pharmadrug Inc. (CSE:BUZZ) is pleased by Germany's Federal Institute of Drugs and Medical Devices' approval of a study evaluating Safety and Efficacy of Psilocybin in Treatment-resistant Depression. First psilocybin study in G...
